Repeated developmental exposure to chlorpyrifos and methyl parathion causes persistent alterations in nicotinic acetylcholine subunit mRNA expression with chlorpyrifos altering dopamine metabolite levels

Neurotoxicology and Teratology

Volumn 31, Issue 2, 2009, Pages 98-103

  Eells, Jeffrey B ^a   Brown, Timothy ^a  

^a MISSISSIPPI STATE UNIVERSITY   (United States)

Author keywords

6 Nicotinic receptor; Dopamine; Nicotinic acetylcholine receptors; Organophosphates

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; ALPHA6 NICOTINIC ACETYLCHOLINE RECEPTOR; BUNGAROTOXIN RECEPTOR; CHLORPYRIFOS; CORN OIL; DOPAMINE; HOMOVANILLIC ACID; NICOTINIC RECEPTOR; NUCLEAR RECEPTOR RELATED FACTOR 1; PARATHION METHYL; PROTEIN LMX1B; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE METABOLISM; EXPOSURE; FEMALE; MALE; METABOLITE; NEUROCHEMISTRY; NEUROTRANSMISSION; NONHUMAN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SUBSTANTIA NIGRA;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; ANIMALS, NEWBORN; CHLORPYRIFOS; CHOLINESTERASE INHIBITORS; CORPUS STRIATUM; DNA-BINDING PROTEINS; DOPAMINE; FEMALE; HOMEODOMAIN PROTEINS; HOMOVANILLIC ACID; INSECTICIDES; MALE; METHYL PARATHION; NERVE TISSUE PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NICOTINIC; SUBSTANTIA NIGRA; TIME FACTORS; TRANSCRIPTION FACTORS;

RATTUS; ZEA MAYS;

EID: 61849169630     PISSN: 08920362     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ntt.2008.10.002     Document Type: Article

References (44)

1. Aldridge J.E., Meyer A., Seidler F.J., and Slotkin T.A. Alterations in central nervous system serotonergic and dopaminergic synaptic activity in adulthood after prenatal or neonatal chlorpyrifos exposure. Environ. Health Perspect. 113 (2005) 1027-1031
2. Allam M.F., Campbell M.J., Hofman A., Del Castillo A.S., and Fernandez-Crehuet Navajas R. Smoking and Parkinson's disease: systematic review of prospective studies. Mov. Disord. 19 (2004) 614-621
3. Ascherio A., Chen H., Weisskopf M.G., O'Reilly E., McCullough M.L., Calle E.E., Schwarzschild M.A., and Thun M.J. Pesticide exposure and risk for Parkinson's disease. Ann. Neurol. 60 (2006) 197-203
4. Azam L., Chen Y., and Leslie F.M. Developmental regulation of nicotinic acetylcholine receptors within midbrain dopamine neurons. Neuroscience (2006)
5. Belluardo N., Mudo G., Blum M., and Fuxe K. Central nicotinic receptors, neurotrophic factors and neuroprotection. Behav. Brain Res. 113 (2000) 21-34
6. Bloomquist J.R., Barlow R.L., Gillette J.S., Li W., and Kirby M.L. Selective effects of insecticides on nigrostriatal dopaminergic nerve pathways. Neurotoxicology 23 (2002) 537-544
7. Brown T.P., Rumsby P.C., Capleton A.C., Rushton L., and Levy L.S. Pesticides and Parkinson's disease-is there a link?. Environ. Health Perspect 114 (2006) 156-164
8. Castillo S.O., Baffi J.S., Palkovits M., Goldstein D.S., Kopin I.J., Witta J., Magnuson M.A., and Nikodem V.M. Dopamine biosynthesis is selectively abolished in substantia nigra/ventral tegmental area but not in hypothalamic neurons in mice with targeted disruption of the Nurr1 gene. Mol. Cell. Neurosci. 11 (1998) 36-46
9. Dam K., Garcia S.J., Seidler F.J., and Slotkin T.A. Neonatal chlorpyrifos exposure alters synaptic development and neuronal activity in cholinergic and catecholaminergic pathways. Brain Res. Dev. Brain Res. 116 (1999) 9-20
10. Eells J.B., Misler J.A., and Nikodem V.M. Reduced tyrosine hydroxylase and GTP cyclohydrolase mRNA expression, tyrosine hydroxylase activity, and associated neurochemical alterations in Nurr1-null heterozygous mice. Brain Res. Bull. 70 (2006) 186-195
11. Ferrari R., Le Novere N., Picciotto M.R., Changeux J.P., and Zoli M. Acute and long-term changes in the mesolimbic dopamine pathway after systemic or local single nicotine injections. Eur. J. Neurosci. 15 (2002) 1810-1818
12. Frigerio R., Sanft K.R., Grossardt B.R., Peterson B.J., Elbaz A., Bower J.H., Ahlskog J.E., de Andrade M., Maraganore D.M., and Rocca W.A. Chemical exposures and Parkinson's disease: a population-based case-control study. Mov. Disord. 21 (2006) 1688-1692
13. Fukuto T.R. Mechanism of action of organophosphorus and carbamate insecticides. Environ. Health Perspect 87 (1990) 245-254
14. Gilbert F., Morissette M., St-Hilaire M., Paquet B., Rouillard C., Di Paolo T., and Levesque D. Nur77 hene knockout alters dopamine neuron biochemical activity and dopamine turnover. Biol. Psychiatry (2006)
15. Gorell J.M., Johnson C.C., Rybicki B.A., Peterson E.L., Kortsha G.X., Brown G.G., and Richardson R.J. Occupational exposure to manganese, copper, lead, iron, mercury and zinc and the risk of Parkinson's disease. Neurotoxicology 20 (1999) 239-247
16. Gorell J.M., Peterson E.L., Rybicki B.A., and Johnson C.C. Multiple risk factors for Parkinson's disease. J. Neurol. Sci. 217 (2004) 169-174
17. Gotti C., Zoli M., and Clementi F. Brain nicotinic acetylcholine receptors: native subtypes and their relevance. Trends Pharmacol. Sci. 27 (2006) 482-491
18. Karen D.J., Li W., Harp P.R., Gillette J.S., and Bloomquis J.R. Striatal dopaminergic pathways as a target for the insecticides permethrin and chlorpyrifos. Neurotoxicology 22 (2001) 811-817
19. Kellendonk C., Simpson E.H., Polan H.J., Malleret G., Vronskaya S., Winiger V., Moore H., and Kandel E.R. Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning. Neuron 49 (2006) 603-615
20. Klink R., de Kerchove d'Exaerde A., Zoli M., and Changeux J.P. Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei. J. Neurosci. 21 (2001) 1452-1463
21. Lang A.E., and Lozano A.M. Parkinson's disease. First of two parts. N. Engl. J. Med. 339 (1998) 1044-1053
22. Lang A.E., and Lozano A.M. Parkinson's disease. Second of two parts. N. Engl. J. Med. 339 (1998) 1130-1143
23. Le Novere N., Zoli M., and Changeux J.P. Neuronal nicotinic receptor alpha 6 subunit mRNA is selectively concentrated in catecholaminergic nuclei of the rat brain. Eur. J. Neurosci. 8 (1996) 2428-2439
24. le Novere N., Zoli M., Lena C., Ferrari R., Picciotto M.R., Merlo-Pich E., and Changeux J.P. Involvement of alpha6 nicotinic receptor subunit in nicotine-elicited locomotion, demonstrated by in vivo antisense oligonucleotide infusion. Neuroreport 10 (1999) 2497-2501
25. Mameli-Engvall M., Evrard A., Pons S., Maskos U., Svensson T.H., Changeux J.P., and Faure P. Hierarchical control of dopamine neuron-firing patterns by nicotinic receptors. Neuron 50 (2006) 911-921
26. Matsubayashi H., Inoue A., Amano T., Seki T., Nakata Y., Sasa M., and Sakai N. Involvement of alpha7- and alpha4beta2-type postsynaptic nicotinic acetylcholine receptors in nicotine-induced excitation of dopaminergic neurons in the substantia nigra: a patch clamp and single-cell PCR study using acutely dissociated nigral neurons. Brain Res. Mol. Brain Res. 129 (2004) 1-7
27. O'Neill M.J., Murray T.K., Lakics V., Visanji N.P., and Duty S. The role of neuronal nicotinic acetylcholine receptors in acute and chronic neurodegeneration. Curr. Drug Targets CNS Neurol. Disord. 1 (2002) 399-411
28. Quik M., and Kulak J.M. Nicotine and nicotinic receptors; relevance to Parkinson's disease. Neurotoxicology 23 (2002) 581-594
29. Quik M., Chen L., Parameswaran N., Xie X., Langston J.W., and McCallum S.E. Chronic oral nicotine normalizes dopaminergic function and synaptic plasticity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned primates. J. Neurosci. 26 (2006) 4681-4689
30. Richardson J.R., and Chambers J.E. Effects of repeated oral postnatal exposure to chlorpyrifos on cholinergic neurochemistry in developing rats. Toxicol. Sci. 84 (2005) 352-359
31. Roy T.S., Seidler F.J., and Slotkin T.A. Morphologic effects of subtoxic neonatal chlorpyrifos exposure in developing rat brain: regionally selective alterations in neurons and glia. Brain Res. Dev. Brain Res. 148 (2004) 197-206
32. Sanchez-Santed F., Canadas F., Flores P., Lopez-Grancha M., and Cardona D. Long-term functional neurotoxicity of paraoxon and chlorpyrifos: behavioural and pharmacological evidence. Neurotoxicol. Teratol. 26 (2004) 305-317
33. Saucedo-Cardenas O., Quintana-Hau J.D., Le W.D., Smidt M.P., Cox J.J., De Mayo F., Burbach J.P., and Conneely O.M. Nurr1 is essential for the induction of the dopaminergic phenotype and the survival of ventral mesencephalic late dopaminergic precursor neurons. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 4013-4018
34. Serova L., and Sabban E.L. Involvement of alpha 7 nicotinic acetylcholine receptors in gene expression of dopamine biosynthetic enzymes in rat brain. J. Pharmacol. Exp. Ther. 303 (2002) 896-903
35. Slotkin T.A., Tate C.A., Cousins M.M., and Seidler F.J. Functional alterations in CNS catecholamine systems in adolescence and adulthood after neonatal chlorpyrifos exposure. Brain Res. Dev. Brain Res. 133 (2002) 163-173
36. Smidt M.P., Asbreuk C.H., Cox J.J., Chen H., Johnson R.L., and Burbach J.P. A second independent pathway for development of mesencephalic dopaminergic neurons requires Lmx1b. Nat. Neurosci. 3 (2000) 337-341
37. Soreq H., and Seidman S. Acetylcholinesterase-new roles for an old actor. Nat. Rev. Neurosci. 2 (2001) 294-302
38. Tang J., Carr R.L., and Chambers J.E. The effects of repeated oral exposures to methyl parathion on rat brain cholinesterase and muscarinic receptors during postnatal development. Toxicol. Sci. 76 (2003) 400-406
39. Tanner C.M., Goldman S.M., Aston D.A., Ottman R., Ellenberg J., Mayeux R., and Langston J.W. Smoking and Parkinson's disease in twins. Neurology 58 (2002) 581-588
40. Wallen A., Zetterstrom R.H., Solomin L., Arvidsson M., Olson L., and Perlmann T. Fate of mesencephalic AHD2-expressing dopamine progenitor cells in NURR1 mutant mice. Exp. Cell Res. 253 (1999) 737-746
41. Wooltorton J.R., Pidoplichko V.I., Broide R.S., and Dani J.A. Differential desensitization and distribution of nicotinic acetylcholine receptor subtypes in midbrain dopamine areas. J. Neurosci. 23 (2003) 3176-3185
42. Wu J., George A.A., Schroeder K.M., Xu L., Marxer-Miller S., Lucero L., and Lukas R.J. Electrophysiological, pharmacological, and molecular evidence for alpha7-nicotinic acetylcholine receptors in rat midbrain dopamine neurons. J. Pharmacol. Exp. Ther. 311 (2004) 80-91
43. Zetterstrom R.H., Solomin L., Jansson L., Hoffer B.J., Olson L., and Perlmann T. Dopamine neuron agenesis in Nurr1-deficient mice. Science 276 (1997) 248-250
44. Zhou F.M., Liang Y., and Dani J.A. Endogenous nicotinic cholinergic activity regulates dopamine release in the striatum. Nat. Neurosci. 4 (2001) 1224-1229